Fri, Nov 28, 2014, 1:30 PM EST - U.S. Markets closed early today

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • ghostinthemachine81 ghostinthemachine81 Sep 14, 2013 11:08 AM Flag

    Big Pharmas real agenda is to block biosimilars not support development...DO NOT TRUST PFIZER!!!

    California Assembly Passes Bill on Biosimilar Drug Use
    By Mark Melnicoe - Aug 27, 2013 12:01 AM PT

    Pharmaceutical makers won approval from the California Assembly to restrict generic versions of drugs isolated from natural sources, such as vaccines, known as biosimilars, once they become available in the U.S.

    The bill passed yesterday would require pharmacies to notify doctors and sometimes patients when a cheaper biosimilar drug is substituted for a brand-name medicine. It also would forbid a pharmacist from substituting the biosimilar drug if the physician says no.

    Biosimilars are generic versions of drugs derived from living cells, known as biologics, for chronic diseases and conditions including cancer, heart disease and diabetes. Drugmakers such as Thousand Oaks, California-based Amgen Inc. (AMGN), which holds patents on biologics, want to limit the use of biosimilars. Global sales of biologics jumped 69 percent in five years to $157 billion in 2011, according to IMS Health, a health-care data provider based in Danbury, Connecticut.

 
PLX
2.10-0.01(-0.47%)1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.